Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)Published
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- European journal of cancer (Oxford, England : 1990)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Gastrointestinal Stromal Tumors; Constipation; Urea; Naphthyridines; Quality of Life; Imatinib Mesylate; Patient Reported Outcome Measures; Sunitinib; Quality of life; Gastrointestinal Stromal Tumours; Protein Kinase Inhibitors
- PubMed ID
- 37598656
- Added to directory
- Source checked